Walsh Protocol Biotype + Methylation Panel — Initial Consultation

This nutrient therapy consultation for depression and anxiety provides a comprehensive physician-reviewed assessment for patients seeking a structured, biochemically guided approach to mood, anxiety, OCD, focus, behavior, stress tolerance, and related symptoms.

The consultation is based on Walsh Protocol principles and includes review of both the Comprehensive Biotype Panel and methylation-related testing. This combined approach is intended for patients who need a more complete initial review of biotype patterns, methylation status, mineral balance, nutrient deficiencies, and related biochemical factors that may influence depression, anxiety, irritability, obsessive tendencies, fatigue, sleep, cognition, or emotional regulation.

Why Biotype and Methylation Testing Are Reviewed Together

A biotype assessment may help identify patterns such as copper overload, pyroluria, undermethylation, overmethylation, mineral imbalance, histamine-related patterns, vitamin D deficiency, homocysteine imbalance, and other nutrient-related findings.

Methylation testing may add additional information about methylation pathway function, including markers such as SAM, SAH, methionine, homocysteine, adenosine, and related pathway findings when available.

Reviewing these two areas together may help clarify cases where symptoms do not fit neatly into one pattern, where the patient has sensitivity to supplements, where prior treatment has produced mixed results, or where methylation support needs to be considered carefully.

What This Consultation Includes

This consultation includes physician review of the submitted questionnaire, Comprehensive Biotype Panel, methylation panel, relevant history, symptom pattern, and prior treatment response when available.

The written assessment may address methylation status, copper/zinc balance, ceruloplasmin, free copper pattern, whole blood histamine, urinary pyrroles, homocysteine, vitamin D, CBC, CMP, SAM, SAH, methionine, adenosine, and related findings when available.

The report includes an interpretation of the likely biochemical patterns and a personalized nutrient or supplement plan when appropriate. Recommendations may include nutrients to consider, nutrients to avoid, dosing guidance, sequencing, safety considerations, and areas where follow-up testing or future modification may be needed.

A physician phone call is included to review the written assessment, answer questions, and discuss next steps.

When This Option Is Appropriate

This option may be appropriate for patients seeking a more complete initial Walsh Protocol assessment for depression, anxiety, OCD, irritability, panic, poor stress tolerance, fatigue, insomnia, brain fog, emotional sensitivity, or mixed mood and behavioral symptoms.

It may also be appropriate for patients specifically looking for an undermethylation consultation, copper overload consultation, pyroluria consultation, methylation panel consultation, or a physician-reviewed nutrient therapy plan based on both biotype and methylation markers.

This option is often a better fit than a biotype-only assessment when methylation status is unclear, symptoms are complex, homocysteine or histamine patterns need more context, prior supplement responses have been confusing, or the patient wants a deeper review before beginning a nutrient therapy plan.

Lab and Questionnaire Review

This consultation is designed for patients completing the Comprehensive Biotype Panel and methylation panel through Second Opinion Physician.

The assessment may also incorporate outside labs when relevant, although outside labs may require additional review if results come from different laboratories, different dates, different formats, incomplete panels, or unrelated testing.

When some lab information is incomplete or unavailable, recommendations are made more conservatively, with attention to safety, tolerance, and the need for modification over time.

Nutrient Therapy Plan

Treatment recommendations emphasize individualized nutrient therapy rather than generic supplementation.

The plan may address which nutrients are most consistent with the patient’s pattern, which supplements may need to be avoided, and where treatment should proceed cautiously because of methylation imbalance, copper/zinc status, pyroluria, sensitivity, toxic burden, or incomplete lab information.

Follow-up modification is often expected as symptoms, tolerance, and lab response become clearer over time.

What This Consultation Does Not Include

This service provides clinical interpretation and nutrient-based guidance. It does not include emergency care, psychiatric crisis care, medication management, primary care management, or diagnosis and treatment of unrelated medical conditions unless specifically discussed and accepted as part of the review.

Patients with urgent symptoms, suicidal thoughts, severe psychiatric instability, chest pain, neurological emergencies, or other serious symptoms should seek immediate local medical care or emergency services.

Note: The consultation includes preparation of a written assessment and a physician phone discussion reviewing findings, recommendations, and next steps.

Recommendations are based on the submitted questionnaire, available lab results, prior information when available, and physician review. Follow-up testing or later adjustment may be needed as clinical response becomes clearer.